DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
-0.94%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$14.6B
AUM Growth
+$1.72B
(+13%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
8.54%
Top 10 Holdings %
Top 10 Hldgs %
17.61%
Holding
1,254
New
218
Increased
469
Reduced
438
Closed
101
Top Buys
| 1 |
Verizon
VZ
|
+$109M |
| 2 |
NextEra Energy, Inc.
NEE
|
+$59.3M |
| 3 |
Microsoft
MSFT
|
+$53.5M |
| 4 |
Alibaba
BABA
|
+$52.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.9M |
Top Sells
| 1 |
Deutsche Bank
DB
|
+$108M |
| 2 |
Booking.com
BKNG
|
+$46.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$34M |
| 4 |
FMC
FMC
|
+$31.5M |
| 5 |
Charter Communications
CHTR
|
+$28.1M |
Sector Composition
| 1 | Technology | 18.61% |
| 2 | Financials | 16.51% |
| 3 | Healthcare | 15.5% |
| 4 | Communication Services | 10.5% |
| 5 | Consumer Discretionary | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Semtech
SMTC
$5.26B
| $286K | ﹤0.01% |
7,400
| – | – |
|
952
Range Resources
RRC
$8.11B
| $284K | ﹤0.01% |
18,363
+145
| +0.8% | +$2.24K |
|
|
CCXI
953
DELISTED
ChemoCentryx, Inc.
CCXI
| $280K | ﹤0.01% |
+20,000
| New | +$280K |
|
954
Boston Beer
SAM
$2.45B
| $274K | ﹤0.01% |
+1,450
| New | +$274K |
|
955
Karyopharm Therapeutics
KPTI
$54.2M
| $269K | ﹤0.01% |
+1,353
| New | +$269K |
|
956
Banco Bradesco
BBD
$33.3B
| $263K | ﹤0.01% |
40,216
-7,906
| -16% | -$51.7K |
|
957
Cerus
CERS
$249M
| $259K | ﹤0.01% |
47,000
-1,000
| -2% | -$5.51K |
|
|
BUFF
958
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $259K | ﹤0.01% |
+6,500
| New | +$259K |
|
|
ADAP
959
Adaptimmune Therapeutics
ADAP
$11.3M
| $257K | ﹤0.01% |
+24,500
| New | +$257K |
|
960
ITT
ITT
$13.5B
| $254K | ﹤0.01% |
+5,300
| New | +$254K |
|
|
ACHN
961
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $253K | ﹤0.01% |
68,300
-1,500
| -2% | -$5.56K |
|
962
Novavax
NVAX
$1.26B
| $252K | ﹤0.01% |
6,155
-125
| -2% | -$5.12K |
|
963
Sabre
SABR
$686M
| $251K | ﹤0.01% |
10,545
-1,141
| -10% | -$27.2K |
|
964
Grupo Aeroportuario del Sureste
ASR
$10.2B
| $250K | ﹤0.01% |
1,496
+38
| +3% | +$6.35K |
|
965
Imperial Oil
IMO
$44.5B
| $248K | ﹤0.01% |
9,574
-111,852
| -92% | -$2.9M |
|
|
STML
966
DELISTED
Stemline Therapeutics, Inc.
STML
| $246K | ﹤0.01% |
+15,600
| New | +$246K |
|
967
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $245K | ﹤0.01% |
21,900
-500
| -2% | -$5.59K |
|
968
AutoNation
AN
$8.57B
| $244K | ﹤0.01% |
4,934
-984
| -17% | -$48.7K |
|
969
Marriott Vacations Worldwide
VAC
$2.71B
| $240K | ﹤0.01% |
1,795
-101
| -5% | -$13.5K |
|
|
HRC
970
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $238K | ﹤0.01% |
2,767
+47
| +2% | +$4.04K |
|
971
Aclaris Therapeutics
ACRS
$225M
| $234K | ﹤0.01% |
+12,700
| New | +$234K |
|
|
GRA
972
DELISTED
W.R. Grace & Co.
GRA
| $234K | ﹤0.01% |
3,457
-577
| -14% | -$39.1K |
|
973
Grupo Aeroportuario del Pacifico
PAC
$12.6B
| $232K | ﹤0.01% |
2,368
+34
| +1% | +$3.33K |
|
974
Rigel Pharmaceuticals
RIGL
$733M
| $232K | ﹤0.01% |
+6,250
| New | +$232K |
|
975
Omeros
OMER
$287M
| $229K | ﹤0.01% |
+19,200
| New | +$229K |
|